• US Department of State reached out to Dr. Oakley-Girvan, SVP of
  Research and Strategy, to invite Medable to attend as a fully
  sponsored entrepreneurial and innovative company
• Summit will focus on global opportunities for the next wave of
  entrepreneur-led innovation in scalable tech, from artificial
  intelligence and robotics to blockchain and big data

PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc.
a leading provider of an innovative end-to-end platform for digitally
enabled and data-driven clinical trials, has been invited as a US
Department of State and Dutch government fully sponsored attendee to the
2019 Global
Entrepreneurship Summit (GES) from June 3-5, 2019, in The Hague,
Netherlands.

Hosted by two of the world’s most innovative countries, the United
States and the Netherlands, this 9^th edition of GES will
focus on global opportunities for the next wave of entrepreneur-led
innovation in scalable tech, from artificial intelligence and robotics
to blockchain, big data, and new science.

Ingrid Oakley-Girvan, PhD, MPH, SVP of Research and Strategy at Medable,
will be representing the company at the Summit. She also represents
Medable on the NSBA Technology Committee and the Economic Council as
well as the Clinical Trials Transformation Initiative (CTTI) that brings
together clinical trial stakeholders. These roles elegantly align with
Medable’s goals to radically accelerate delivery of therapies and cures
to patients through innovative clinical trial support and analytic
approaches.

“We are delighted that Medable has been chosen for the highly selective
US and Dutch government all expenses sponsored attendee award this year.
I know Dr. Oakley-Girvan is looking forward to interacting with other
top global innovators, corporate partners and thought leaders at the
Summit,” said Dr. Michelle Longmire, CEO and co-founder of Medable.
“We’re the most secure platform in healthcare with the only
globally-compliant HIPAA and EU-compliant cloud solution software. Our
platform was built with a specific purpose in mind, to enable life
science companies to bring new therapies to patients faster for improved
patient outcomes.”

About GES

Initiated nearly a decade ago by the U.S. Government, the Global
Entrepreneurship Summit (GES) is the pre-eminent annual gathering of
entrepreneurs, innovators, investors, and thought leaders from around
the world, providing a unique event that is a combination of an
innovation marketplace and policy forum.

Attracting 2,000 industry-leading participants from more than 120
countries to The Hague, this year’s Summit offers unmatched
opportunities for businesses looking to scale up. 1,200 hand-picked
entrepreneurs will engage with 300+ investors managing trillions of
dollars of assets, as well as top policymakers, corporate partners and
thought leaders to accelerate solutions.

About Medable

Medable is a privately held, venture-backed company headquartered in
Palo Alto, California. Medable is on a mission to get effective
therapies to patients faster by dramatically reducing the time from
therapeutic development to market realization with digital data capture
and real-time analytics that remove the complexities of clinical
research to dramatically reduce trial timelines. Medable is pioneering a
new category of life science technologies that replace the stagnant and
siloed data of traditional ePRO, eCOA, EDC, and eSource with an
intelligent and unified end-to-end (E2E) platform for clinical trial
execution. Medable’s E2E platform allows patients, healthcare providers,
clinical research organizations and pharmaceutical sponsors to work
together as a connected and empowered team in clinical trials and
research.

For more information, visit www.medable.com and
follow Medable on Twitter: @Medableinc

Contacts

Investors
Medable
investors@medable.com

Media
Kimberly Ha
KKH Advisors
kimberly.ha@kkhadvisors.com
917-291-5744